Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;24(3):462-464.
doi: 10.1111/1756-185X.14077. Epub 2021 Feb 4.

Autoantibodies in severe COVID-19-related acute respiratory distress syndrome: Just innocent bystanders?

Michele Umbrello  1 , Stefano Nespoli  1 , Eleonora Pisano  1 , Cecilia Bonino  1 , Stefano Muttini  1
Affiliations

Autoantibodies in severe COVID-19-related acute respiratory distress syndrome: Just innocent bystanders?

Michele Umbrello et al. Int J Rheum Dis. 2021 Mar.
No abstract available

Keywords: Autoantibodies; autoimmunity; coronavirus disease 2019; critically ill; severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Conflict of interest statement

None declared.

References

    1. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS‐CoV‐2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574‐1581. - PMC - PubMed
    1. Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID‐19) in Wuhan. China. Clin Infect Dis. 2020;71(15):762‐768. - PMC - PubMed
    1. Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762. - PMC - PubMed
    1. Gazzaruso C, Carlo Stella N, Mariani G, et al. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS‐CoV2 pneumonia. Clin Rheumatol. 2020;39(7):2095‐2097. - PMC - PubMed
    1. Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID‐19). J Transl Autoimmun. 2020;3:100073. - PMC - PubMed